Literature DB >> 14604505

Central and peripheral sensitization in tension-type headache.

Lars Bendtsen1.   

Abstract

Recent studies on tension-type headache indicate that the nociceptive input to the central nervous system may be increased as a result of activation or sensitization of peripheral sensory afferents. Moreover, pain perception studies and pharmacologic studies strongly suggest that the central nervous system is sensitized in patients with chronic tension-type headache. The barrage of nociceptive impulses from the periphery may be responsible for the sensitization of second- and third-order neurons in the central nervous system. In this way, sensitization may play a role in the initiation and maintenance of tension-type headache. Studies have demonstrated that treatment with drugs that counteract sensitization has an analgesic effect on tension-type headache. Targeting this mode of action seems to be a promising way of improving the treatment for this prevalent disorder.

Entities:  

Mesh:

Year:  2003        PMID: 14604505     DOI: 10.1007/s11916-003-0062-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  35 in total

1.  Decreased pain detection and tolerance thresholds in chronic tension-type headache.

Authors:  L Bendtsen; R Jensen; J Olesen
Journal:  Arch Neurol       Date:  1996-04

2.  Pericranial muscle tenderness and exteroceptive suppression of temporalis muscle activity: a blind study of chronic tension-type headache.

Authors:  G L Lipchik; K A Holroyd; F Talbot; M Greer
Journal:  Headache       Date:  1997-06       Impact factor: 5.887

3.  Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache.

Authors:  L Bendtsen; R Jensen
Journal:  Cephalalgia       Date:  2000-07       Impact factor: 6.292

4.  Nitric oxide-induced headache in patients with chronic tension-type headache.

Authors:  M Ashina; L Bendtsen; R Jensen; J Olesen
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

Review 5.  Central sensitization in tension-type headache--possible pathophysiological mechanisms.

Authors:  L Bendtsen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

6.  Lost workdays and decreased work effectiveness associated with headache in the workplace.

Authors:  B S Schwartz; W F Stewart; R B Lipton
Journal:  J Occup Environ Med       Date:  1997-04       Impact factor: 2.162

7.  Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache.

Authors:  J Schoenen; D Bottin; F Hardy; P Gerard
Journal:  Pain       Date:  1991-11       Impact factor: 6.961

8.  Amitriptyline in the treatment of primary headaches.

Authors:  Lars Bendtsen
Journal:  Expert Rev Neurother       Date:  2003-03       Impact factor: 4.618

9.  Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial.

Authors:  M Ashina; L H Lassen; L Bendtsen; R Jensen; J Olesen
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

10.  Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.

Authors:  J C Eisenach; G F Gebhart
Journal:  Anesthesiology       Date:  1995-11       Impact factor: 7.892

View more
  10 in total

1.  Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain.

Authors:  Gary C Anderson; Mike T John; Richard Ohrbach; Donald R Nixdorf; Eric L Schiffman; Edmond S Truelove; Thomas List
Journal:  Pain       Date:  2010-12-31       Impact factor: 6.961

Review 2.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

3.  Tension-type Headache in the Elderly.

Authors:  Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

4.  Evidence of persistent central sensitization in chronic headaches: a multi-method study.

Authors:  Elena Filatova; Nina Latysheva; Alexey Kurenkov
Journal:  J Headache Pain       Date:  2008-08-09       Impact factor: 7.277

5.  Tension-type headache in adolescents and adults: a population based study of 33,764 twins.

Authors:  Michael Bjørn Russell; Niels Levi; Jūrate Saltyte-Benth; Kirsten Fenger
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

6.  Similarities in stress physiology among patients with chronic pain and headache disorders: evidence for a common pathophysiological mechanism?

Authors:  Rune Bang Leistad; Kristian Bernhard Nilsen; Lars Jacob Stovner; Rolf Harald Westgaard; Magne Rø; Trond Sand
Journal:  J Headache Pain       Date:  2008-03-29       Impact factor: 7.277

7.  Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache.

Authors:  Rune Bang Leistad; Lars Jacob Stovner; Linda R White; Kristian B Nilsen; Rolf H Westgaard; Trond Sand
Journal:  J Headache Pain       Date:  2007-06-11       Impact factor: 7.277

8.  Cardiovascular responses to cognitive stress in patients with migraine and tension-type headache.

Authors:  Rune B Leistad; Trond Sand; Kristian B Nilsen; Rolf H Westgaard; Lars Jacob Stovner
Journal:  BMC Neurol       Date:  2007-08-07       Impact factor: 2.474

9.  Alterations in Surface Electromyography Are Associated with Subjective Masticatory Muscle Pain.

Authors:  Davide Pietropaoli; Eleonora Ortu; Mario Giannoni; Ruggero Cattaneo; Alessandra Mummolo; Annalisa Monaco
Journal:  Pain Res Manag       Date:  2019-11-22       Impact factor: 3.037

Review 10.  The fifth cranial nerve in headaches.

Authors:  J C A Edvinsson; A Viganò; A Alekseeva; E Alieva; R Arruda; C De Luca; N D'Ettore; I Frattale; M Kurnukhina; N Macerola; E Malenkova; M Maiorova; A Novikova; P Řehulka; V Rapaccini; O Roshchina; G Vanderschueren; L Zvaune; A P Andreou; K A Haanes
Journal:  J Headache Pain       Date:  2020-06-05       Impact factor: 8.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.